Managing obesity has become easier with the advent of new medication-based therapies, which treat it like other chronic diseases. A new class of revolutionary therapeutics - GLP-1 agonists (specifically Ozempic and Mounjaro) have allowed recipients to make more insulin and regulate their appetite, which has means they can be used for obesity management and weight loss.  

 

Health professionals at Arc-1 Metrics can customize a healthcare plan for men and women to optimize their weight and overall well-being with suitable exercise routines and therapeutics based solely on your specific concerns.

 

About Ozempic and Mounjaro

 

Both Ozempic and Mounjaro have been found to help people with type 2 diabetes lose some weight. In clinical trials, people taking The body weight of individuals taking Ozempic decreased by an average of 2-3 pounds, while those taking Mounjaro experienced an average weight loss of 3-4 pounds.

 

When used for weight loss rather than diabetes, these drugs produced even more dramatic weight loss results, with Ozempic users losing an average of around 10 pounds and Mounjaro users experiencing weight loss of up to 15 pounds.

 

How Do They Work?

 

Ozempic has Semaglutide in it and is sold under a specific name. It is a GLP-1 receptor agonist that increases the insulin produced by the pancreas after eating. This helps reduce blood sugar levels and improves glycemic control in people with type 2 diabetes.

 

Mounjaro has Tirzepatide in it and is also a GLP-1 receptor agonist. It is a dual-agonist that works on GIP too. It stimulates insulin production after meals like Ozempic, and it is used for the same purpose.

 

Both of these substances have the ability to attach to the GLP-1 receptor present in the brain, pancreas, and stomach. This attachment can modify the signaling pathways that control your hunger, the feeling of satiety, and insulin resistance.

 

Are You A Good Candidate For Ozempic or Mounjaro-Induced Weight Loss?

 

Both Ozempic and Mounjaro are medications that are approved by the FDA for treating Type 2 diabetes. Even though they are not explicitly approved for weight loss, they are sometimes prescribed for obesity because they can help people lose weight.

 

If you have a BMI of 27 or higher and weight-related illnesses such as hypertension, high cholesterol, PCOS, or heart conditions, you may be eligible for weight loss medications.

 

If you or any of your family members have had a condition called medullary thyroid carcinoma (MTC) or an endocrine system disorder known as Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), it is not recommended for you to take Ozempic or Mounjaro.

 

Whether these medications can help you or how much weight you lose on them will depend on several factors, such as where you are on your journey and your ability to stick to a treatment plan.

​

About Us

 

Arc-1 Metrics appreciates that people have numerous commitments to fulfill, such as family, work, and community responsibilities. Under the guidance of Dr. Todd A. Stearns, DO, FACOG, we collaborate with our clients to enable them to reach their wellness objectives and aspirations, providing an array of packages and treatment programs designed for weight loss, women's health, men's health, and more.

 

Book an appointment for Weight Loss Treatment

 

Mounjaro is a medication for adults with type 2 diabetes that is administered as a weekly injection and works to reduce blood sugar levels. Mounjaro via telehealth is a convenient solution for patients without a provider to obtain Mounjaro medication. With Mounjaro online prescription, patients can access the medication and start their treatment promptly.

 

For assistance with weight loss treatments, the best approach is to consult an expert at Arc-1 Metrics and explore the available packages and programs to choose one best suited for your needs. Our professional healthcare providers can assist you in determining the best plan for you. To set up a meeting with one of our health professionals specializing in weight loss assistance at Arc-1 Metrics, schedule a consultation.